Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A
- 1 December 1986
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 54 (3) , 735-741
- https://doi.org/10.1128/iai.54.3.735-741.1986
Abstract
The capsule of Cryptococcus neoformans is an important virulence factor. In this investigation capsular polysaccharides (CPSs) were isolated by ethanol precipitation from culture filtrates of C. neoformans serotype A strains 6, 15, 98, 110, and 145. Capsule sizes on India ink examination ranged from barely perceptible (strain 15) to greater than the diameter of the yeast cell (strain 6); the others were intermediate in size. On ion-exchange chromatography on DEAE-cellulose each CPS eluted at 0.2 M NaCl; CPS of strain 15 had two major peaks, designated III and IV. On gel-permeation chromatography CPSs of strains 6, 98, 110, and 145 eluted at the void volume of Sepharose CL-2B in the presence or 0.1 M EDTA, while the CPS of strain 15 eluted in two peaks. Sephacryl S-1000 resolved CPSs of all five strains in the following order, from largest to smallest molecular size: 145 greater than 110 greater than 98 greater than 6 much greater than 15. All five CPSs contained mannose, xylose, and glucuronic acid, while the carboxyl-reduced CPS of strain 110 also contained a large percentage of an inositol-like compound. The CPS of strain 110 contained approximately 30% uronic acid by weight, while the others had 15 to 20%. The composition of peak IV from the CPS of strain 15 resembled those of the other strains; peak III of strain 15 contained a substantial amount of galactose. Each CPS contained less than 0.2% protein by weight. The significant differences in molecular size and sugar composition among CPSs of these strains of C. neoformans serotype A may partially explain strain differences in virulence and biological properties of the organism.This publication has 32 references indexed in Scilit:
- Culture of Cryptococcus neoformans in the nonencapsulated stateMycopathologia, 1981
- Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype AMolecular Immunology, 1980
- Structural studies on the major, capsular polysaccharide from Cryptococcus bacillisporus serotype BCarbohydrate Research, 1980
- The structure of the capsular polysaccharide from crytococcus neoformans serotype dCarbohydrate Research, 1979
- On the structure of the capsular polysaccharide from Cryptococcus neoformans serotype c—IIMolecular Immunology, 1979
- Molecular weight dependence of the anticoagulant properties of heparin: Intravenous and subcutaneous administration of fractionated heparins to manThrombosis Research, 1979
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- Stoichiometric depolymerization of polyuronides and glycosaminoglycuronans to monosaccharides following reduction of their carbodiimide-activated carboxyl groupBiochemistry, 1972
- Investigations on the structure of the capsular polysaccharide from Cryptococcus Neoformans type BBiochimica et Biophysica Acta (BBA) - General Subjects, 1966
- VIRULENCE AND GROWTH RATES OF CRYPTOCOCCUS NEOFORMANS IN MICEAnnals of the New York Academy of Sciences, 1960